Ohki Health Care Holdings, Inc. (3417) AI Stock Analysis

• Market Cap: ¥18.99B
• Dividend Yield: 1.83%
• Average Volume (3M): 8.64K
• Price to Earnings (P/E): 14.6
• Beta (1Y): 0.52
• Revenue Growth: 4.30%
• EPS Growth: 52.38%
• Country: JP
• Employees: 632
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Pharmaceuticals
• EPS (TTM): 24.44
• Shares Outstanding: 14,072,100
• 10 Day Avg. Volume: 11,730
• 30 Day Avg. Volume: 8,636
• PEG Ratio: 0.20
• Price to Book (P/B): 0.35
• Price to Sales (P/S): 0.03
• P/FCF Ratio: -0.91
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 63 Neutral
• Price Target: ¥1,364.00 ▼(-4.08% Downside)
• Action: Downgraded Date: 02/07/26
• Date: Action: Downgraded 02/07/26

The score is driven primarily by solid financial performance (growth and improving operating efficiency) tempered by cash flow and leverage concerns. Technical indicators are notably weak and pull the score down, while the low P/E and moderate dividend yield partially offset these risks.

Positive Factors

Revenue Growth

Consistent revenue growth indicates a robust market position and effective product distribution, enhancing long-term business stability.

Operational Efficiency

Improved operational efficiency suggests the company is optimizing its processes, which can lead to sustained profitability and competitive advantage.

Product Innovation

Investment in R&D for product innovation can drive market share expansion and long-term growth, keeping the company competitive.

Negative Factors

Rising Leverage

Increased leverage can strain financial resources, potentially impacting the company's ability to invest in growth and manage economic downturns.

Negative Free Cash Flow

Negative free cash flow suggests challenges in cash management, which could affect the company's ability to fund operations and growth initiatives.

Low Net Profit Margin

A low net profit margin indicates potential inefficiencies or high costs, which could limit the company's ability to generate sustainable profits.

Ohki Health Care Holdings, Inc. Business Overview & Revenue Model

Company Description

Ohki Healthcare Holdings Co.,Ltd. distributes pharmaceutical products, health foods, dairy products, cosmetics, and daily necessities. The company imports, exports, and sells pharmaceuticals, quasi-drugs, medical equipment, cosmetics, poisons and deleterious substances, drugs, reagents, measuring instruments, optical instruments, electrical products, communication equipment, veterinary drugs, veterinary medical equipment, pet supplies, feed, feed additives, textile products, sanitary products, beauty and health equipment, sports equipment, leisure goods, nursing goods, nursing convenience goods, toys, stationery, homes supplies, daily necessities, groceries, food additives, alcoholic beverages, rice grains, salt, and cigarettes. It also provides chemicals, fertilizers, pesticides, gardening supplies, and agricultural supplies, as well as engages in the warehousing, information processing systems, distribution system equipment, and software development activities. In addition, the company engages in the pharmacy/drug store management and dispensing service, and nursing service businesses; manufacture and sale of pharmaceuticals, quasi-drugs, cosmetics, health foods, killing agents, medical and sanitary products, soft drinks, medical skin care, health food, and miscellaneous goods. Further, it is involved in the manufacture and wholesale of environmental conservation products; and wholesale of food and contact products, cosmetics, and miscellaneous goods, as well as license application agency business. The company was founded in 1658 and is headquartered in Tokyo, Japan.

How the Company Makes Money

Ohki Health Care Holdings generates revenue through multiple channels. The primary revenue streams include the sale of pharmaceutical products and medical devices, which are distributed both domestically and internationally. The company also engages in health services, providing patient care and management solutions that contribute to its earnings. Strategic partnerships with healthcare providers and research institutions play a crucial role in expanding its market reach and enhancing its product offerings. Additionally, Ohki Health Care leverages licensing agreements and collaborations for research initiatives, further diversifying its income sources.

Ohki Health Care Holdings, Inc. Financial Statement Overview

Summary

Revenue growth and improving EBIT/EBITDA margins support fundamentals, but rising leverage and negative free cash flow in the latest year increase financial risk and weigh on the score.

Income Statement

Ohki Health Care Holdings, Inc. has shown consistent revenue growth over the years, with a notable increase from 2024 to 2025. The gross profit margin has been stable, indicating efficient cost management. However, the net profit margin is relatively low, suggesting room for improvement in profitability. EBIT and EBITDA margins have improved, reflecting better operational efficiency.

Balance Sheet

The company's debt-to-equity ratio has increased, indicating higher leverage, which could pose a risk if not managed properly. Return on equity has been positive, showing the company is generating profits from shareholders' investments. The equity ratio indicates a moderate level of financial stability, but the increase in total debt warrants caution.

Cash Flow

The cash flow statement reveals challenges, with negative free cash flow in the latest year, indicating potential liquidity issues. The operating cash flow to net income ratio is negative, suggesting cash flow management needs improvement. Despite these concerns, the company has managed to maintain positive operating cash flows in previous years.

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	352.90B	349.45B	334.66B	304.44B	278.16B	270.93B
Gross Profit	19.01B	18.19B	17.20B	15.88B	13.72B	15.51B
EBITDA	4.61B	4.29B	3.82B	3.59B	1.95B	4.50B
Net Income	2.83B	2.64B	2.21B	2.18B	972.00M	2.75B
Balance Sheet
Total Assets	141.50B	139.34B	138.58B	122.54B	113.95B	110.96B
Cash, Cash Equivalents and Short-Term Investments	3.49B	2.88B	8.31B	3.24B	2.77B	2.80B
Total Debt	13.41B	14.17B	6.95B	8.46B	7.48B	8.59B
Total Liabilities	110.48B	108.28B	110.68B	98.27B	91.86B	88.82B
Stockholders Equity	30.96B	30.99B	27.84B	24.13B	21.95B	21.93B
Cash Flow
Free Cash Flow	0.00	-12.03B	7.23B	-223.00M	1.17B	-4.43B
Operating Cash Flow	0.00	-9.18B	7.55B	96.00M	1.31B	-4.27B
Investing Cash Flow	0.00	-3.13B	-496.00M	-291.00M	68.00M	710.00M
Financing Cash Flow	0.00	6.89B	-2.00B	681.00M	-1.40B	2.36B

Ohki Health Care Holdings, Inc. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1422.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3417, the sentiment is Negative. The current price of 1422 is above the 20-day moving average (MA) of 1346.70, above the 50-day MA of 1392.64, and above the 200-day MA of 1307.30, indicating a neutral trend. The MACD of -9.81 indicates Negative momentum. The RSI at 43.06 is Neutral, neither overbought nor oversold. The STOCH value of 33.62 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:3417.

Ohki Health Care Holdings, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
7649	75 Outperform	¥664.75B	23.30	15.71%	0.96%	21.81%	67.76%
3148	75 Outperform	¥206.41B	13.66	―	2.35%	7.55%	16.01%
3391	67 Neutral	¥1.02T	25.31	―	1.72%	―	―
3549	67 Neutral	¥354.25B	20.79	―	0.41%	15.81%	27.05%
3417	63 Neutral	¥18.99B	14.56	―	1.83%	4.30%	52.38%
3349	60 Neutral	¥535.71B	22.79	―	0.93%	3.73%	18.84%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%